Patents Assigned to Aesculus Bio ApS
  • Publication number: 20220064217
    Abstract: The present invention relates to new peptides derived from HD-5 or HNP-4 having antimicrobial activity for use in modulating the microbiome of intestines, the lungs, the skin, the mouth, the eye, the ear, the vagina or other bodily surfaces and/or for use as an antimicrobial agent in a human or other mammals, as well as to medicaments containing these peptides.
    Type: Application
    Filed: January 7, 2020
    Publication date: March 3, 2022
    Applicant: Aesculus Bio ApS
    Inventors: Jan Wehkamp, Dirk Ehmann